ANAB vs BRO · rev $234.6M vs P/E 30, rev $3.58B
AnaptysBio Inc (ANAB) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
ANAB currently screens at market cap $1.62B. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the ANAB and BRO stock pages for the full models.
Not investment advice.